Wanbangde Pharmaceutical Holding Group Balance Sheet Health
Financial Health criteria checks 5/6
Wanbangde Pharmaceutical Holding Group has a total shareholder equity of CN¥2.8B and total debt of CN¥948.2M, which brings its debt-to-equity ratio to 34.3%. Its total assets and total liabilities are CN¥4.3B and CN¥1.5B respectively. Wanbangde Pharmaceutical Holding Group's EBIT is CN¥68.9M making its interest coverage ratio 1.9. It has cash and short-term investments of CN¥95.8M.
Key information
34.3%
Debt to equity ratio
CN¥948.22m
Debt
| Interest coverage ratio | 1.9x |
| Cash | CN¥95.80m |
| Equity | CN¥2.76b |
| Total liabilities | CN¥1.50b |
| Total assets | CN¥4.27b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002082's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥1.3B).
Long Term Liabilities: 002082's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥211.8M).
Debt to Equity History and Analysis
Debt Level: 002082's net debt to equity ratio (30.8%) is considered satisfactory.
Reducing Debt: 002082's debt to equity ratio has reduced from 66.3% to 34.3% over the past 5 years.
Debt Coverage: 002082's debt is well covered by operating cash flow (21.9%).
Interest Coverage: 002082's interest payments on its debt are not well covered by EBIT (1.9x coverage).